Abstract
LT3001 is a novel small molecule designed to have thrombolytic and free radical scavenging activities. Its potential safety and efficacy in treating acute ischemic stroke was evaluated using a thromboembolic stroke model in adult Cynomolgus macaque.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
